Innovative Drug Developer As founder of Cage Pharma, Dr. Jeff Geschwind, MD channels his research into novel cancer drugs. His work focuses on disrupting tumor metabolism, specifically targeting glycolysis, to stop cancer growth at a fundamental level. https://www.bumc.bu.edu/camed/offices-services/alumni/alumni-recognition-resources/alumni-awards-submission/past-recipients-of-the-alumni-awards/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/